Literature DB >> 30592624

High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.

Stanton J Kochanek1, David A Close1, Paul A Johnston1,2.   

Abstract

Multicellular tumor spheroid (MCTS) cultures represent more physiologically relevant in vitro cell tumor models that recapitulate the microenvironments and cell-cell or cell-extracellular matrix interactions which occur in solid tumors. We characterized the morphologies, viability, and growth behaviors of MCTSs produced by 11 different head and neck squamous cell carcinoma (HNSCC) cell lines seeded into and cultured in ultra-low attachment microtiter plates (ULA-plates) over extended periods of time. HNSCC MCTS cultures developed microenvironments, which resulted in differences in proliferation rates, metabolic activity, and mitochondrial functional activity between cells located in the outer layers of the MCTS and cells in the interior. HNSCC MCTS cultures exhibited drug penetration and distribution gradients and some developed necrotic cores. Perhaps the most profound effect of culturing HNSCC cell lines in MCTS cultures was their dramatically altered and varied growth phenotypes. Instead of the exponential growth that are characteristic of two-dimensional HNSCC growth inhibition assays, some MCTS cultures displayed linear growth rates, categorized as rapid, moderate, or slow, dormant MCTSs remained viable but did not grow, and some MCTSs exhibited death phenotypes that were either progressive and slow or rapid. The ability of MCTS cultures to develop microenvironments and to display a variety of different growth phenotypes provides in vitro models that are more closely aligned with solid tumors in vivo. We anticipate that the implementation MCTS models to screen for new cancer drugs for solid tumors like HNSCC will produce leads that will translate better in in vivo animal models and patients.

Entities:  

Keywords:  3D microenvironments; head and neck squamous cell carcinoma; multicellular tumor spheroids

Year:  2018        PMID: 30592624      PMCID: PMC6352515          DOI: 10.1089/adt.2018.896

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  65 in total

Review 1.  Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture.

Authors:  Sarah-Louise Ryan; Anne-Marie Baird; Gisela Vaz; Aaron J Urquhart; Mathias Senge; Derek J Richard; Kenneth J O'Byrne; Anthony M Davies
Journal:  Assay Drug Dev Technol       Date:  2016-01-27       Impact factor: 1.738

2.  Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation.

Authors:  Manjulata Singh; David A Close; Shilpaa Mukundan; Paul A Johnston; Shilpa Sant
Journal:  Assay Drug Dev Technol       Date:  2015-08-14       Impact factor: 1.738

Review 3.  Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues.

Authors:  Brendon M Baker; Christopher S Chen
Journal:  J Cell Sci       Date:  2012-07-13       Impact factor: 5.285

Review 4.  Emerging biomarkers in head and neck cancer in the era of genomics.

Authors:  Hyunseok Kang; Ana Kiess; Christine H Chung
Journal:  Nat Rev Clin Oncol       Date:  2014-11-18       Impact factor: 66.675

Review 5.  Drug penetration in solid tumours.

Authors:  Andrew I Minchinton; Ian F Tannock
Journal:  Nat Rev Cancer       Date:  2006-08       Impact factor: 60.716

6.  Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection.

Authors:  Hua Li; John S Wawrose; William E Gooding; Levi A Garraway; Vivian Wai Yan Lui; Noah D Peyser; Jennifer R Grandis
Journal:  Mol Cancer Res       Date:  2014-01-14       Impact factor: 5.852

7.  Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation.

Authors:  Maria Vinci; Sharon Gowan; Frances Boxall; Lisa Patterson; Miriam Zimmermann; William Court; Cara Lomas; Marta Mendiola; David Hardisson; Suzanne A Eccles
Journal:  BMC Biol       Date:  2012-03-22       Impact factor: 7.431

8.  Comprehensive genomic characterization of head and neck squamous cell carcinomas.

Authors: 
Journal:  Nature       Date:  2015-01-29       Impact factor: 49.962

9.  Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes.

Authors:  Vonn Walter; Xiaoying Yin; Matthew D Wilkerson; Christopher R Cabanski; Ni Zhao; Ying Du; Mei Kim Ang; Michele C Hayward; Ashley H Salazar; Katherine A Hoadley; Karen Fritchie; Charles J Sailey; Charles G Sailey; Mark C Weissler; William W Shockley; Adam M Zanation; Trevor Hackman; Leigh B Thorne; William D Funkhouser; Kenneth L Muldrew; Andrew F Olshan; Scott H Randell; Fred A Wright; Carol G Shores; D Neil Hayes
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

10.  3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.

Authors:  Amy L Howes; Robyn D Richardson; Darren Finlay; Kristiina Vuori
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

View more
  7 in total

1.  Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells.

Authors:  Angelina Huseinovic; Annelieke Jaspers; Annina P van Splunter; Hanne Sørgård; Saskia M Wilting; Dorian R A Swarts; Ida H van der Meulen; Victor W van Beusechem; Renée X de Menezes; Renske D M Steenbergen
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

2.  Maximizing the Value of Cancer Drug Screening in Multicellular Tumor Spheroid Cultures: A Case Study in Five Head and Neck Squamous Cell Carcinoma Cell Lines.

Authors:  Stanton J Kochanek; David A Close; Daniel P Camarco; Paul A Johnston
Journal:  SLAS Discov       Date:  2020-01-25       Impact factor: 3.341

3.  Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening.

Authors:  Larisa Goričan; Boris Gole; Uroš Potočnik
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

Review 4.  Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research.

Authors:  Bárbara Pinto; Ana C Henriques; Patrícia M A Silva; Hassan Bousbaa
Journal:  Pharmaceutics       Date:  2020-12-06       Impact factor: 6.321

5.  Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy.

Authors:  Vinzenz Särchen; Senthan Shanmugalingam; Sarah Kehr; Lisa Marie Reindl; Victoria Greze; Sara Wiedemann; Cathinka Boedicker; Maureen Jacob; Katrin Bankov; Nina Becker; Sibylle Wehner; Till M Theilen; Steffen Gretser; Elise Gradhand; Carsten Kummerow; Evelyn Ullrich; Meike Vogler
Journal:  Cell Death Discov       Date:  2022-01-10

Review 6.  In vitro models for head and neck cancer: Current status and future perspective.

Authors:  Christian R Moya-Garcia; Hideaki Okuyama; Nader Sadeghi; Jianyu Li; Maryam Tabrizian; Nicole Y K Li-Jessen
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738

Review 7.  In vitro models as tools for screening treatment options of head and neck cancer.

Authors:  Barbara Seliger; Ahmed Al-Samadi; Bo Yang; Tuula Salo; Claudia Wickenhauser
Journal:  Front Med (Lausanne)       Date:  2022-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.